Clinical Trials Browser

Recruiting × INDUSTRY × Hydroxyurea × Clear all

NCT07190833 2026-04-09

A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)

Phase 1 Recruiting

Other solid neoplasm

Treatment-Refractory Solid Tumors

NCT06093672 2026-03-25

GIV-IN-PV

Phase 3 Recruiting

Polycythemia Vera

NCT07033598 2026-03-05

PROSPERA

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic